Sodium-glucose Co-transporter-2 Inhibitor
1 clinical trials · Condition
◉ Watch Sodium-glucose Co-transporter-2 Inhibitor
| Record | Firm | Date |
|---|---|---|
| The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics (NCT06059287) | RenJi Hospital | 2023-10-01 |
Track Sodium-glucose Co-transporter-2 Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.